Humanwell unit Hubei Bio-Pharma Industry Tech Institute wins China approval to start trials of HWS113 injection for chronic pruritusPUBT·Jun 29 at 08:42 AM600079-0.17%
HWHG: Pregabalin sustained-release tablets have received the drug clinical trial approval noticeZhitong·Nov 3, 2025 at 01:45 AM600079-0.17%
HWHG: Shareholders holding more than 5% of shares have completed the commitment to acquire Wuhu Xinfeng's stakeZhitong·Oct 30, 2025 at 02:47 AM600079-0.17%
HWHG: Dapoxetine Hydrochloride Tablets have obtained the drug registration certificateZhitong·Oct 13, 2025 at 04:47 AM600079-0.17%
HWHG: Oxcarbazepine extended-release tablets received a tentative approval number from the U.S. FDAZhitong·Sep 19, 2025 at 02:38 AM600079-0.17%
HWHG: Flurbiprofen Ester Injection has obtained a drug registration certificateZhitong·Sep 16, 2025 at 03:19 AM600079-0.17%
HWHG: Levonorgestrel tablets have obtained a drug registration certificateZhitong·Sep 16, 2025 at 03:19 AM600079-0.17%
HWHG: Yu Can Granules enter Phase II clinical trial researchZhitong·Sep 9, 2025 at 02:54 AM600079-0.17%
The three major A-share indices closed mixed, with WESTERN REGION GOLD hitting the daily limit36Kr·Sep 3, 2025 at 02:06 AM601069+4.26%600079-0.17%
The concept of innovative drugs rebounds, BHC and HWHG hit the limit upZhitong·Sep 2, 2025 at 09:53 PM600721+2.63%600079-0.17%
HWHG: Eicosapentaenoic Acid Ethyl Ester Soft Capsules Obtain Drug Registration CertificateZhitong·Sep 2, 2025 at 04:02 AM600079-0.17%
HWHG: The injectable remimazolam benzenesulfonate has received a drug registration certificate for new indicationsZhitong·Aug 25, 2025 at 03:48 AM600079-0.17%
HWHG: HW241045 tablets have received approval for clinical trialsZhitong·Aug 5, 2025 at 02:53 AM600079-0.17%
JD.com and HWHG hold talks on full-chain cooperation in the pharmaceutical fieldAASTOCKS·Aug 3, 2025 at 06:16 PM600079-0.17%JD+2.17%
HWHG is in talks with JD Group for a full-chain collaboration in the pharmaceutical fieldZhitong·Aug 2, 2025 at 10:33 PM600079-0.17%
